Table 4.
Patient Sample Identification | Sample type | Staining Intensity | Subcellular localization | Fraction of cells stained | Age |
---|---|---|---|---|---|
Patient 2252 | Lobular carcinoma | weak | Cytoplasmic/membranous | <25% | 47 |
Patient 2898 | Lobular carcinoma | weak | Cytoplasmic/membranous, nuclear | 25–75% | 41 |
Patient 3535 | Lobular carcinoma | weak | Cytoplasmic/membranous | 25–75% | 47 |
Patient 2565 | Lobular carcinoma | moderate | Cytoplasmic/membranous | >75% | 51 |
Patient 2428 | Ductal carcinoma | moderate | Cytoplasmic/membranous | >75% | 75 |
Patient 1910 | Ductal carcinoma | moderate | Cytoplasmic/membranous | >75% | 61 |
Patient 2091 | Ductal carcinoma | moderate | Cytoplasmic/membranous | >75% | 40 |
Patient 3257 | Ductal carcinoma | weak | Nuclear | 25–75% | 39 |
Tumor sample profile depicting sample type, staining intensity, subcellular localization, fraction of cells stained, and patient age.